GlassScriptPhysician profile
Alan Blank
NPI 1841581220
$92,352.84
in general payments reported to CMS, 2019-2025
10 companies · $22K in 2025
The $22K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $8,313 · 2021: $9,652 · 2022: $19K · 2023: $21K · 2024: $12K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $45K · Travel and Lodging: $5,700 · Honoraria: $2,400 · Food and Beverage: $1,743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $45,274.00 |
| Travel and Lodging | $5,699.88 |
| Honoraria | $2,400.00 |
| Food and Beverage | $1,743.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Onkos Surgical, INC. | $71,484.00 | 2019-2025 | Eleos Limb Salvage System |
| Medical Device Business Services, INC. | $9,996.56 | 2025 | Lcp, Tfn-Advance, Na |
| Signature Orthopaedics USA Corp | $4,000.00 | 2023-2025 | |
| Emd Serono, INC. | $3,260.25 | 2025 | |
| Deciphera Pharmaceuticals INC. | $2,616.60 | 2024 | Vimseltinib |
| Depuy Synthes Sales INC. | $367.12 | 2023-2025 | Na |
| Integrum INC. | $279.93 | 2022 | |
| Smith+Nephew, INC. | $131.63 | 2024 | Aetos Shoulder System |
| Stryker Corporation | $129.50 | 2019 | |
| Carbofix Orthopedics INC | $87.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Blank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.